Literature DB >> 10071909

Expression and functional role of nitric oxide synthase isoforms in human osteoblast-like cells.

H MacPherson1, B S Noble, S H Ralston.   

Abstract

Previous studies have shown evidence of constitutive and cytokine-inducible nitric oxide (NO) synthase activity in cultured osteoblast-like cells from various species. Although cytokine-induced NO production has been found to inhibit osteoblast growth, the role of constitutive NO production in regulating osteoblast function is less clear and the isoforms of nitric oxide synthase (NOS) that are expressed by human osteoblasts have not been determined. Here, we investigated NOS expression in cultured human osteoblast-like cells and studied the effects of constitutive and cytokine-induced NO on osteoblast growth and differentiation. Low levels of NO were produced constitutively by osteoblast-like cells as reflected by analysis of medium nitrite concentrations, and evidence of ecNOS mRNA, protein, and bioactivity was found in primary osteoblasts (hOBs), TE85, and MG63 osteosarcoma cells. None of the osteoblast-like cells expressed nNOS, however, and iNOS was produced only by hOB cells after stimulation with the cytokines IL-1beta, TNF-alpha, and IFN-gamma. The NOS inhibitor, L-NMMA, did not affect growth or alkaline phosphatase activity in unstimulated osteoblasts. Incubation of hOB cells with cytokines inhibited growth and stimulated alkaline phosphatase activity and these effects were abrogated by L-NMMA. Cytokines also inhibited growth of TE85 cells and MG63 cells, but these effects appeared to be NO independent because they were not influenced by L-NMMA. Our experiments show that human osteoblasts constitutively produce NO through the ecNOS pathway, but demonstrate that this does not appear to exert an appreciable effect on osteoblast growth or differentiation under basal conditions. In contrast, IL-1beta, TNF-alpha, and IFN-gamma exerted growth-inhibiting and differentiation-inducing effects on osteoblasts that were partly NO dependent, indicating that NO may act predominantly as a modulator of cytokine-induced effects on osteoblast function.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10071909     DOI: 10.1016/s8756-3282(98)00173-2

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  20 in total

Review 1.  Nitric oxide and bone.

Authors:  R J van't Hof; S H Ralston
Journal:  Immunology       Date:  2001-07       Impact factor: 7.397

2.  Expression of endothelial nitric oxide synthase protein is not necessary for mechanical strain-induced nitric oxide production by cultured osteoblasts.

Authors:  V Das-Gupta; R A Williamson; A A Pitsillides
Journal:  Osteoporos Int       Date:  2012-03-09       Impact factor: 4.507

3.  The bio-functional role of calcium in mesoporous silica xerogels on the responses of osteoblasts in vitro.

Authors:  Huanjun Zhou; Jie Wei; Xiaohui Wu; Jianlin Shi; Changsheng Liu; Junfeng Jia; Chenglong Dai; Qi Gan
Journal:  J Mater Sci Mater Med       Date:  2010-04-22       Impact factor: 3.896

4.  Type II cGMP-dependent protein kinase mediates osteoblast mechanotransduction.

Authors:  Hema Rangaswami; Nisha Marathe; Shunhui Zhuang; Yongchang Chen; Jiunn-Chern Yeh; John A Frangos; Gerry R Boss; Renate B Pilz
Journal:  J Biol Chem       Date:  2009-03-11       Impact factor: 5.157

Review 5.  NO control of mitochondrial function in normal and transformed cells.

Authors:  Celia H Tengan; Carlos T Moraes
Journal:  Biochim Biophys Acta Bioenerg       Date:  2017-02-16       Impact factor: 3.991

6.  Sirt1 overexpression protects murine osteoblasts against TNF-α-induced injury in vitro by suppressing the NF-κB signaling pathway.

Authors:  Wei Huang; Wei-lin Shang; Hua-dong Wang; Wen-wen Wu; Shu-xun Hou
Journal:  Acta Pharmacol Sin       Date:  2012-03-26       Impact factor: 6.150

7.  Comprehensive metabolic characterization of serum osteocalcin action in a large non-diabetic sample.

Authors:  Lukas Entenmann; Maik Pietzner; Anna Artati; Anke Hannemann; Ann-Kristin Henning; Gabi Kastenmüller; Henry Völzke; Matthias Nauck; Jerzy Adamski; Henri Wallaschofski; Nele Friedrich
Journal:  PLoS One       Date:  2017-09-18       Impact factor: 3.240

8.  Treatment with hydrogen molecule alleviates TNFα-induced cell injury in osteoblast.

Authors:  Wen-Wen Cai; Ming-Hua Zhang; Yong-Sheng Yu; Jin-Hua Cai
Journal:  Mol Cell Biochem       Date:  2012-12-01       Impact factor: 3.396

Review 9.  Are cardiovascular disease and osteoporosis directly linked?

Authors:  Crystal Whitney; Darren E R Warburton; Jiri Frohlich; Sammy Y Chan; Heather McKay; Karim Khan
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

Review 10.  Nitric oxide, C-type natriuretic peptide and cGMP as regulators of endochondral ossification.

Authors:  Cristina C Teixeira; Hanga Agoston; Frank Beier
Journal:  Dev Biol       Date:  2008-05-03       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.